| GERN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: GERN Shares Outstanding History and GERN YTD Return |
| GERN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+4.77% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GERN Stock Price Chart |
| About Geron Corp. |
| Geron is a biopharmaceutical company that is focused on the development and commercialization of imetelstat, a telomerase inhibitor. Co. is conducting two ongoing Phase 3 clinical trials that are designed to enable registration of imetelstat: (i) IMerge Phase 3 in lower risk myelodysplastic syndromes (MDS), and (ii) IMpactMF in refractory myelofibrosis (MF). Imetelstat has been granted Fast Track designations by the U.S. Food and Drug Administration for the treatment of patients with transfusion-dependent anemia due to lower risk MDS and who are refractory or resistant to treatment with an erythropoiesis stimulating agent and for the treatment of patients with MF. We show 56 historical shares outstanding datapoints in our GERN shares outstanding history coverage, used to compute GERN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing GERN market cap history over the course of time is important for investors interested in comparing GERN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of GERN versus a peer is one thing; comparing GERN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like GERN can fluctuate over the course of history. With this page we aim to empower investors researching GERN by allowing them to research the GERN market cap history. |
| GERN Current Stock Quote |
 Free GERN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| GERN Share Performance |
| Market Cap Peers |
| Geron (GERN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
GFOR Market Cap History |
